Yesterday, I received an explanation of the microarray results. This test was performed to get more detailed results because the G-banding method could not determine the extent of the 5p deletion or ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Consumables held the largest share at 73.4% in 2025. The global biomarkers market is projected to grow to $112.1b by 2031, ...

Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...

The SureScan Microarray Scanner is a key component of Agilent’s complete microarray solution. With improved feature resolution, it delivers exceptional flexibility to analyze any microarray ...

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe ...

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The ...

According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...

Raphas, a mass-production platform company specializing in microneedle technology, has teamed up with Japanese electronics ...

TROP2抗体药物偶联物（antibody-drug conjugates, ADCs）已显示出有前景的抗肿瘤活性，但此类药物在肺大细胞神经内分泌癌（large cell neuroendocrine carcinoma, LCNEC）中的活性以及TROP2表 TROP2抗体药物偶联物（antibody-drug conjugates, ADCs）已显示出有前景的抗肿瘤活性，但此类药物在肺大细胞神 ...

Postdoctoral researchers face extreme career precarity. Funding pressures and systemic bottlenecks have sparked a global movement to restructure postdoctoral training.